Flexible, Simplified, and Scalable Solutions for AAV Viral Vector Production

WEBINAR

The adeno-associated virus (AAV) is the leading viral vector for in vivo gene therapy. Currently, production is labor intensive and expensive because of adherent cell culture processes. The use of stirred-tank bioreactors allows scalable and robust processes to be developed to meet the most demanding needs for high-dose indications that target large organs, e.g. muscle, skin, or blood. High-performing cell culture media is also crucial to ensure consistent supply.

Here, we highlight the development of two suspension-based AAV upstream production platforms and describe simplified cell culture processes to enable an efficient and cost-effective solution for large-scale AAV production.

In this webinar, you will learn about:

• Market insights, overall process considerations & trends for AAV
• High-performing suspension-based AAV upstream production platforms: VirusExpress^® and Sf-RVN^®
• Simplifying and optimizing your HEK-based suspension cell culture processes with the new Cellvento^® 4HEK